|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0014 - 0.0016|
|52 Week Range||0.0008 - 0.0520|
|Beta (5Y Monthly)||2.52|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Las Vegas, Nevada--(Newsfile Corp. - April 27, 2022) - IFAN FINANCIAL Inc. (OTC PINK: IFAN), IFAN begins discussions with 503b lab to manufacture and distribute a proprietary psychedelic Ketamine product for IFAN.IFAN looks forward to opening clinics focused on mental health. The psychedelic industry's market is over $240B. Depression is a common mental disorder. Globally, it is estimated that 245 million adults suffer from depression worldwide. Ketamine is set up to help with mental ...
Las Vegas, Nevada--(Newsfile Corp. - April 18, 2022) - IFAN FINANCIAL Inc., (OTC Pink: IFAN). It is our commitment to provide transparency to our shareholders. We are moving as planned to complete our corporate goals and provide profit to our investors. Since our acquisition of IFAN September 2021 we have worked tirelessly to develop our business and provide clarity to the public market. Our management team is working on some phenomenal developments, and we ...
Las Vegas, Nevada--(Newsfile Corp. - February 22, 2022) - IFAN FINANCIAL Inc. (OTC Pink: IFAN), is pleased to announce that it has applied for name and ticker change with FINRA (the "Financial Industry Regulatory Authority" corporation). Once name and ticker change are approved it will be revealed publicly. The new focus includes Biosciences and Mental Health. This corporate action opens a new chapter for the company as it allows the new name and ...